|
 |
rDNA originThis page contains recent news articles, when available, and an overview of rDNA origin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....as well as in endocrinology, with Saizen® (somatropin (rDNA origin) for injection) and Serostim® (somatropin (rDNA origin) for injection). ... PR Newswire (press release) IS YOUR CHILD ALWAYS IN THE - Dec 21, 2009 Fortunately, if detected early enough, growth hormone deficiency may be treatable with growth hormone treatments such as Saizen® [somatropin (rDNA origin) ... North American Press Syndicate Data Analysis Reinforces the Safety Profile of Levemir(R) - Oct 20, 2009 About Levemir® Levemir® (insulin detemir [rDNA origin] injection) is a man-made long-acting insulin that is used to control high blood sugar in adults and ... Reuters NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance - Nov 4, 2009 NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is being evaluated in a Phase 3 registration study known as REPLACE as a hormone replacement ... WELT ONLINE Video: EMD Serono Holds Topping Off Ceremony to Mark Milestone in the ... - Oct 19, 2009 ...as well as in endocrinology, with Saizen(®) (somatropin (rDNA origin) for injection) and Serostim(®) (somatropin (rDNA origin) for injection). ... Reuters Wellstat, Sanofi Ink $350M Deal for Phase II Insulin Sensitizer - Oct 21, 2009 Sanofi's once-daily long-acting insulin product Lantus (insulin glargine rDNA origin), which works for 24 hours with no pronounced peak, is the world leader ... BioWorld Online NPS Pharmaceuticals to Report Third Quarter Financial Results on November 4, 2009 - Oct 29, 2009 NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is being evaluated in a Phase 3 registration study known as REPLACE as a hormone replacement ... WELT ONLINE Data Demonstrate That GATTEX (Teduglutide) Improves Lean Body Mass, Mineral ... - Oct 26, 2009 NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is being evaluated in a Phase 3 registration study known as REPLACE as a hormone replacement ... Reuters Novo-Nordisk：Novo Nordiské•¿æ•ˆèƒ°å²›ç´ ä¸Žç™Œç—‡å¹¶å?‘çŽ‡è¾ƒé«˜æ— å…³ - Oct 20, 2009 ...(NVO) 65.27 : Novo-NordISk A/S宣布，临床数æ?®åˆ†æž?ç»“æžœæ˜¾ç¤ºï¼Œç›¸è¾ƒæ–¼äººç±»èƒ°å²›ç´ ï¼ŒNovo Nordiské•¿æ•ˆèƒ°å²›ç´ Levemir (insulin detemir [rDNA origin]注射å£)与癌症病例 ... 凤凰网 Un estudio de Novartis determina que Aclasta®, en combinación con teriparatida ... - Oct 20, 2009 2 Forteoâ„¢ (teriparatide [rDNA origin] injection). Prescribing Information. Indianapolis, IN: Eli Lilly and Company. July 2009. 3 Reclast (zoledronic acid) ... Noticias Médicas (Comunicado de prensa) … ORC contains a ribosomal RNA fragment that participates in rDNA... - Nov 15, 2007 Sequence alignment and in vitro targeting of 26T RNA to the rDNA origin. ... A minimum three-fold enrichment of the rDNA origin region was observed in four ... Nature.com … ORC contains a ribosomal RNA fragment that participates in rDNA... - Nov 15, 2007 Gel shift analysis of 26T RNA base-pairing mutants. (A) Sequence of wild-type (WT) and 26T RNA derivatives (M, R, L and F) carrying mutations in the ... Nature.com … NovoLog(R) (Insulin Aspart [rDNA Origin] Injection) for Treatment... - Sep 15, 2005 PRINCETON, NJ, Sept. 15 /PRNewswire/ -- Novo Nordisk Inc. announced today that the US Food and Drug Administration (FDA) has approved the supplemental new ... RedOrbit … ORC contains a ribosomal RNA fragment that participates in rDNA... - Nov 15, 2007 Functional analysis of ORC1 knockdown mutants. (A) Disruption of the ORC1 gene in the polyploid macronucleus. Top: schematic of wild-type ORC1 and the ORC1 ... Nature.com Article: Maker of AIDS Drug Fined for Kickbacks - The Washington Post... - Oct 18, 2005 Article: Serostim, Serono's Human Growth Hormone (rDNA Origin) for ... ... FDA) has granted full approval for Serostim(R) [somatropin (rDNA origin) for ... Pay-Per-View - Washington Post - HighBeam Research … Analog Levemir (Insulin Detemir [rDNA Origin] Injection) Available... - May 17, 2006 Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal insulin analog indicated for once- or twice-daily subcutaneous administration for ... DG News Lilly Launches KwikPen(TM) for Humalog(R) and Humalog Mixtures - Feb 21, 2008 50% insulin lispro injection [rDNA origin]). The Humalog brand of insulins are indicated for use in patients with diabetes to control high blood sugar. ... Reuters UK Apidra (insulin glulisine [rDNA origin] injection) Now Available in... - Feb 28, 2006 BRIDGEWATER, NJ -- February 28, 2006 -- Sanofi-aventis US announced today that Apidra® (insulin glulisine [rDNA origin] injection), a new prandial or ... DG News … Approves Levemir(R) (Insulin Detemir [rDNA Origin] Injection) - a... - Jun 17, 2005 PRINCETON, NJ, June 17 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced today that the US Food and Drug Administration (FDA) has approved Levemir(R) ... RedOrbit Article: Fla. Medicaid program recoups $54.1 million from European... - Oct 18, 2005 Article: Serostim, Serono's Human Growth Hormone (rDNA Origin) for ... ... FDA) has granted full approval for Serostim(R) [somatropin (rDNA origin) for ... Pay-Per-View - South Florida Sun - Sentinel - HighBeam Research Taking Teriparatide (rDNA origin) Injection from Consumer Reports … - Jan 9, 2008 Teriparatide injection causes osteosarcoma (cancer of the bones) in laboratory rats. It is possible ... Full Alert. Teriparatide injection may cause side ... consumerreports.org … Approves NovoLog(r) (insulin aspart [rDNA origin] injection) for... - Sep 23, 2005 Novo Nordisk Inc announced today that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) of NovoLog(R) ... Medical News Today - Medical News Today (press release) Learn about Insulin Detemir (rDNA Origin) Injection from Consumer … - Jan 10, 2006 Insulin detemir is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in ... consumerreports.org Learn about Teriparatide (rDNA origin) Injection from Consumer... - Jan 9, 2008 Teriparatide injection causes osteosarcoma (cancer of the bones) in laboratory rats. It is possible ... Full Alert. Teriparatide injection is used to treat ... consumerreports.org Taking Insulin Detemir (rDNA Origin) Injection from Consumer Reports ... - Jan 10, 2006 This medication may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms. ... consumerreports.org Learn about Insulin Glulisine (rDNA origin) Injection from Consumer … - Jan 5, 2007 Insulin glulisine is used to treat type 1 diabetes (condition in which the body does not make insulin and therefore cannot control the amount of sugar in ... consumerreports.org … approves Levemir [insulin detemir (rDNA Origin) Injection] for... - Oct 20, 2005 Novo Nordisk Inc announced that the US Food and Drug Administration (FDA) has approved Levemir [insulin detemir (rDNA origin) injection] for use in children ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Taking Insulin Glulisine (rDNA origin) Injection from Consumer... - Jan 5, 2007 Insulin glulisine may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms. ... consumerreports.org NPS Pharmaceuticals Announces Senior Management Changes - Feb 26, 2008 NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs ... Bloomberg … Drug, Iplex (mecasermin rinfabate [rDNA origin] injection), for... - Dec 13, 2005 2005 -- Insmed Incorporated announced the United States Food and Drug Administration (FDA) approved Iplex(TM) (mecasermin rinfabate (rDNA origin) ... DG News … Video Feed: FDA Approves Exubera(R) (insulin human [rDNA origin]) ... - Jan 27, 2006 NEW YORK, Jan. 27 /PRNewswire/ -- Nearly 21 million Americans suffer from diabetes and the majority of those with type 2 diabetes have uncontrolled blood ... Free with registration - PR Newswire - AccessMyLibrary.com … Pfizer Inc., Exubera (insulin human [rDNA origin]) Inhalation... - Feb 19, 2007 From Pfizer Inc., Exubera (insulin human [rDNA origin]) Inhalation Powder is the first inhaled medication to help manage blood sugar. ... $9.94 - Drug Topics - Alacra Store Insulin as part (rDNA origin) injection (NovoLog, Novo Nordisk) was … - Oct 1, 2005 Insulin as part (rDNA origin) injection (NovoLog, Novo Nordisk) was approved to treat diabetes in children aged 2 to 18 years. Free with registration - Formulary - AccessMyLibrary.com New and generic drug approvals: Humatrope (somatropin [rDNA origin]) ... - Nov 3, 2006 On 3 Nov 2006, the US Food and Drug Administration announced approval (new or modified indication) of NDA 019640 for Humatrope (somatropin [rDNA origin]) ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones … Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the... - Jul 11, 2007 European Commission Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the Treatment of Osteoporosis in Men. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research New and generic drug approvals: Serostim (somatropin [rDNA origin] … - Dec 5, 2006 On 5 Dec 2006, the US Food and Drug Administration announced approval (control supplement) of NDA 020604 for Serostim (somatropin [rDNA origin] injection). ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones Press Release: Sanofi Aventis: People With Type 2 Diabetes Treated... - Sep 10, 2008 Article: Lantus (insulin glargine (rDNA origin) injection) -- The ... Business Wire; May 22, 2001 ; 700+ words ... ... Aventis Pharmaceuticals announced ... Pay-Per-View - PR Newswire Europe - HighBeam Research … NovoLog(R) (Insulin Aspart [rDNA Origin] Injection) for Treatment... - Sep 15, 2005 FDA Approves NovoLog(R) (Insulin Aspart [rDNA Origin] Injection) for Treatment of Diabetes in Children. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Tercica Announces Agreement with Genentech for Worldwide Growth … - Jul 10, 2007 About Increlex([R])(mecasermin [rDNA origin] injection): The active ingredient of ... About Nutropin AQ[R] [somatropin (rDNA origin)]: Nutropin AQ[R] ... Free with registration - Business Wire - AccessMyLibrary.com Press Release: Study Shows Lantus(R) Helped People Living with Type 2... - Jun 7, 2008 Article: Lantus(R) (Insulin Glargine [rDNA Origin] Injection) ... PR Newswire; January 9, 2001 ; 700+ words ... ... diabetes patients who received ... Pay-Per-View - PR Newswire - HighBeam Research … Levemir(R) (Insulin Detemir [rDNA Origin] Injection) for Treatment... - Oct 20, 2005 FDA Approves Levemir(R) (Insulin Detemir [rDNA Origin] Injection) for Treatment of Diabetes in Children. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Sanofi Aventis: People With Type 2 Diabetes Treated... - Sep 10, 2008 Article: Lantus (insulin glargine (rDNA origin) injection) -- The ... Business Wire; May 22, 2001 ; 700+ words ... ... Aventis Pharmaceuticals announced ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Nastech Announces Positive Phase 1 Clinical Results of... - Dec 6, 2006 27 /PRNewswire/ -- Insulin aspart (rDNA origin) injection (brand name ... healthier birth weight(3). "Because insulin aspart acts more rapidly than regular ... Pay-Per-View - PR Newswire - HighBeam Research … Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - a... - Jun 17, 2005 FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - a New, Long-Acting Insulin Treatment for Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Study Shows A1c Reduced Safely By Patients With … - Jun 25, 2007 Article: FDA Approves Levemir(R) (insulin detemir [rDNA Origin] ... PR Newswire; June 17, 2005 ; 700+ words ... ... Drug Administration (FDA) has approved ... Pay-Per-View - PR Newswire - HighBeam Research NPS Pharmaceuticals to Report 2007 Financial Results - Mar 6, 2008 NPS has also completed a Phase 3 osteoporosis study for PREOS(R) (parathyroid hormone 1-84 [rDNA origin] injection). NPS complements its internal programs ... Bloomberg Selected biotechnology, biotech-related, small-molecule and other FDA... - Feb 27, 2006 ...hormone (GH) gene deletion who have developed neutralizing antibodies to GH Levemir Treatment of diabetes mellitus (insulin detemir [rDNA origin](type 1 ... Pay-Per-View - Chain Drug Review - HighBeam Research FDA Approves Levemir(R) (insulin detemir [rDNA Origin] Injection) - Jun 21, 2005 A New, Long-Acting Insulin Treatment for Diabetes. Denmark's Novo Nordisk said on Friday the United States Food and Drug Administration (FDA) has approved ... Diabetes In Control Company Profile Report - Oct 11, 2008 Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Pituitary Gland Disorders. Acromegaly. Somatostatin Analogs ... $50.00 - Revere Reports - Revere Article: Levemir, Trileptal.(New & Approved) - Family Practice News |... - Jan 1, 2006 New & Approved) ... find Family Practice News articles. Levemir (insulin detemir [rDNA origin] injection, Novo Nordisk Inc.) The Food and Drug... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Data Presented at ADA Showed that Basal Insulin … - Jun 13, 2005 About Lantus(R) (insulin glargine [rDNA origin] injection) Lantus(R) is indicated for once-daily subcutaneous ... PR Newswire. Article: Lantus(R) (insulin ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: SoloSTAR(R), the First Prefilled Disposable Insulin... - Jul 30, 2007 Article: Lantus(R) (Insulin Glargine [rDNA Origin] Injection) ... PR Newswire; January 8, 2001 ; 700+ words ... ... diabetes patients who received ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Elite Team of Cyclists with Type 1 Diabetes Powers … - Apr 2, 2008 PR Newswire; February 28, 2006 ; 700+ words ... ... aventis U.S. announced today that Apidra(R) (insulin glulisine [rDNA origin ... patients with type 1 and ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Lilly Launches KwikPen(TM) for Humalog(R) and … - Feb 21, 2008 Eli Lilly and Company permission to market Humalog(R) (insulin lispro (rDNA origin)) for ... the U.S. the twenty first country in which Humalog has been ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Approves NovoLog(R) Category Change for Use in … - Jan 30, 2007 Inc. (NNPI) today announced that NovoLog(R) (insulin aspart, rDNA origin ... of diabetes. "We are pleased to make NovoLog widely available as a treatment ... Pay-Per-View - PR Newswire - HighBeam Research Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat... - Sep 25, 2006 Saizen(R) [somatropin (rDNA origin) for injection] and Zorbtive(TM) [somatropin (rDNA origin) for injection] on the market in the US. ... Free with registration - PR Newswire - AccessMyLibrary.com Article: Inhaled insulin clears hurdle - The Record (Bergen County,... - Mar 3, 2005 Biotech Business; August 1, 2007 ; 700+ words ... ... declines in lung function in diabetes patients who took Exubera (insulin human [rDNA origin]) ... Pay-Per-View - The Record - HighBeam Research Press Release: Lilly Announces Launch of Color Differentiation System... - Oct 27, 2008 LLY) announced today that Humalog(R) Mix75/25(TM) (75% insulin lispro protamine suspension, 25% insulin lispro injection (rDNA origin ... the rapid-acting ... Pay-Per-View - PR Newswire - HighBeam Research Article: New insulin pen.(PRODUCTS)(Lantus)(Brief article) - Internal... - Nov 1, 2007 Article: Lantus (insulin glargine (rDNA origin) injection) -- The ... Business Wire; May 22, 2001 ; 700+ words ... ... Aventis Pharmaceuticals announced ... Pay-Per-View - Internal Medicine News - HighBeam Research Phase III Trial Of Oral Cladribine, A Novel Investigational Therapy... - May 5, 2006 ...[somatropin (rDNA origin) for injection], Saizen(R) [somatropin (rDNA origin) for injection] and Zorbtive(TM) [somatropin (rDNA origin) for injection]. ... Medical News Today - Medical News Today (press release) Article: Ex-Serono sales director accused of kickbacks.(WASHINGTON … - Feb 1, 2005 Article: Serostim, Serono's Human Growth Hormone (rDNA Origin) for ... ... FDA) has granted full approval for Serostim(R) [somatropin (rDNA origin) for ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Eli Lilly, www.humalog.com, is launching KwikPen, a new insulin pen … - Apr 14, 2008 Eli Lilly, www.humalog.com, is launching KwikPen, a new insulin pen prefilled with Humalog (insulin lispro injection [rDNA origin]) insulins. ... $9.94 - Drug Topics - Alacra Store EMD Serono Launches MS LifeLines Access Made Simple, a Program … - Jul 2, 2007 ...(rDNA origin) for injection), Serostim(R) (somatropin (rDNA origin) for injection) and Zorbtive(TM) (somatropin (rDNA origin) for injection). ... Free with registration - PR Newswire - AccessMyLibrary.com Special delivery: new drug devices call for increased patient... - Oct 23, 2006 OptiClik, a reusable insulin delivery device for use with Apidra (insulin glulisine [rDNA origin] injection, SanofiAventis) cartridges; and OptiClik for ... Free with registration - Drug Topics - AccessMyLibrary.com Company Profile Report - Oct 11, 2008 Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Pituitary Gland Disorders. Acromegaly. Somatostatin Analogs ... $50.00 - Revere - Alacra Store Serono Announces Formal Conclusion of Serostim Settlement. - Dec 15, 2005 ...led by the US Attorney's office in Massachusetts into commercial practices related to Serostim(R) [somatropin (rDNA origin) for injection]. ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: LILLY (ELI) & COMPANY - BYETTA Study-Blood Glucose … - Jun 25, 2007 Worldwide, less than ... injection site. About Lantus(R) (insulin glargine [rDNA origin] injection) Lantus ... Business Wire ... Pay-Per-View - PR Newswire UK Disclose - HighBeam Research Article: Arvella's Rx for osteoporosis: forteo and exercise.(Arvella... - Jul 1, 2006 PR Newswire; July 23, 2009 ; 700+ words ... ... approved a new use for its osteoporosis drug FORTEO [teriparatide (rDNA origin) injection ... a reduction in ... Pay-Per-View - Saturday Evening Post - HighBeam Research Article: NPS stock rises 21% on report - Deseret News (Salt Lake... - Sep 7, 2005 PR Newswire; September 27, 2005 ; 700+ words ... ... studies that demonstrate treatment with PREOS(R), parathyroid hormone [rDNA origin ... Nashville. ... Pay-Per-View - Deseret News - HighBeam Research FDA Approves Additional Indication for Norditropin(R) for Small for … - Nov 4, 2008 Norditropin(R) (somatropin [rDNA origin] injection) is indicated for the treatment of children with short stature associated with Noonan syndrome, ... RedOrbit Novo Nordisk Becomes Insulin Market Leader. - Nov 10, 2005 Additionally, we anticipate further growth with the launch of Levemir(R) (insulin detemir [rDNA origin] injection) in 2006. Treating patients with our full ... Free with registration - PR Newswire - AccessMyLibrary.com Focus on 2006: a year of novel pharmacologic agents in review.(Cover ... - Nov 1, 2006 Full-length or intact parathyroid hormone (rDNA origin) for injection (PTH [1-84], Preos, NPS Pharmaceuticals) is under FDA review for the treatment of ... $4.95 - Formulary - ECNext Article: Sanofi sells prefilled disposable pen.(Diabetes)(Brief... - Nov 19, 2007 ...rDNA origin] injection), a prefilled disposable pen containing rapid-acting insulin ... the Apidra(R) SoloSTAR(R) prefilled disposable insulin pen or ... Pay-Per-View - Chain Drug Review - HighBeam Research FDA Safety Labeling Changes: Fluvoxamine Maleate, Norvir, Tev-Tropin - May 25, 2005 Somatropin [rDNA origin] injection is indicated only for the long-term treatment of children who have growth failure due to inadequate secretion of normal ... Medscape FDA Safety Labeling Changes: Duragesic, Candesartan, Serostim LQ - Apr 27, 2005 Somatropin [rDNA origin] for injection is indicated for the treatment of HIV patients with wasting or cachexia to increase lean body mass and body weight ... Medscape Article: Portable diabetes emergency kit.(Products) - Pediatric News... - Nov 1, 2005 Products) ... find Pediatric News articles. The GlucaGen HypoKit (glucagon [rDNA origin] for injection) is available for use to treat severe hypoglycemi... Pay-Per-View - Pediatric News - HighBeam Research Article: Levemir, Rozerem.(New & Approved) - Family Practice News | … - Aug 15, 2005 New & Approved) ... find Family Practice News articles. Levemir (insulin detemir [rDNA origin] injection, Novo Nordisk) A long-acting basal... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Prospective Study Published in Diabetes Care Confirms ... - Jun 9, 2005 Article: Lantus(R) (insulin glargine [rDNA origin] injection) ... PR Newswire; May 8, 2003 ; 700+ words ... ... clinical development program for Lantus(R) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Analyses Show PREOS(R) Improves Bone Strength … - Sep 27, 2005 PR Newswire; September 19, 2007 ; 700+ words ... ... has granted orphan drug designation to PREOS(R) (parathyroid hormone [rDNA origin ... by calcium ... Pay-Per-View - PR Newswire - HighBeam Research Drug/Medical Device Report Tercica, Inc. (TRCA) - Oct 11, 2008 Increlex (Mecasermin rDNA Origin). Crohn Disease In Children. Phase II. Endocrinology/Metabolism. Phase I/Phase II Clinical Stage Products ... $70.00 - Revere Reports - Revere StreetInsider.com Pre-Open Movers 07/11 - Jul 11, 2007 ...recombinant human growth hormone Nutropin AQ (somatropin (rDNA origin)) and ... (mecasermin (rDNA origin) injection) for the treatment of short stature, ... StreetInsider.com - StreetInsider.com (subscription) Clinical Study Results Demonstrated Greater Flexibility With Mealtime... - Jun 13, 2005 About LANTUS(R) (insulin glargine [rDNA origin] injection). LANTUS(R) is indicated for once-daily subcutaneous administration in the treatment of adult ... $4.95 - PR Newswire - ECNext Apidra(R) Improved A1C In People With Type 2 Diabetes When Added to … - Jun 24, 2007 When a single dose of Apidra(R) was added to a basal regimen with Lantus(R) (insulin glargine [rDNA origin] injection) serving as the basal insulin, ... RedOrbit Levemir(R) Helps Patients Significantly and Safely Improve Control in... - Jun 12, 2006 Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal insulin analog indicated for once- or twice-daily subcutaneous administration for ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Novo Nordisk Introduces New Storage Flexibility for … - Jan 11, 2006 Article: Saizen, Serono's Human Growth Hormone (rDNA Origin) ... PR Newswire; October 15, 1996 ; 700+ words ... ... failure due to inadequate levels of ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: FDA Approves Norditropin(R)for Treatment of Short … - Jun 1, 2007 Article: Saizen, Serono's Human Growth Hormone (rDNA Origin) ... PR Newswire; October 15, 1996 ; 700+ words ... ... failure due to inadequate levels of ... Pay-Per-View - PR Newswire - HighBeam Research Novo Nordisk sues Sanofi-Aventis for insulin delivery device patent … - Sep 1, 2005 ...(rDNA origin)), NovoLog (insulin aspart (rDNA origin) injection) and soon-to-be-launched Levemir (insulin detemir (rDNA origin) injection). ... $4.95 - BIOTECH Patent News - ECNext Novo Nordisk Prevails in Sanofi-Aventis Challenge to Levemir(R) -- Up... - Jun 27, 2006 Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal insulin analog indicated for once- or twice-daily subcutaneous administration for ... RedOrbit New Data From Head-To-Head Study Confirms Once-Daily Levemir(R) Is … - Jun 10, 2008 Levemir® (insulin detemir [rDNA origin] injection) is a long-acting insulin analogue indicated for once- or twice-daily subcutaneous administration for the ... Medical News Today - Medical News Today (press release) Brooke Shields Lends Her Support to Encourage Women to Take Action … - Nov 3, 2005 Serostim(R) [somatropin (rDNA origin) for injection], Saizen(R) [somatropin (rDNA origin) for injection] and Zorbtive(TM) [somatropin (rDNA origin) for ... $4.95 - PR Newswire - ECNext Competitors by Product Report - Oct 11, 2008 Products:. Increlex (Mecasermin rDNA Origin)/Nutropin AQ (Somatropin rDNA Origin) Combination Products. Abbott Laboratories (ABT) Products: ... $75.00 - Revere Reports - Revere Press Release: NPS Pharmaceuticals Reports First Quarter 2005 … - May 10, 2005 PR Newswire; September 27, 2005 ; 700+ words ... ... studies that demonstrate treatment with PREOS(R), parathyroid hormone [rDNA origin ... Nashville. ... Pay-Per-View - PR Newswire - HighBeam Research Levemir, Trileptal.(New & Approved) | Article from Pediatric News | … - Dec 1, 2005 New & Approved) ... find Pediatric News articles. Levemir (insulin detemir [rDNA origin] injection, Novo Nordisk Inc.) The Food and Drug Administra... Pay-Per-View - Pediatric News - HighBeam Research Article: BESPAK (BPK). - Investors Chronicle | HighBeam Research - … - Jan 26, 2007 Biotech Business; August 1, 2007 ; 700+ words ... ... declines in lung function in diabetes patients who took Exubera (insulin human [rDNA origin]) ... Pay-Per-View - Investors Chronicle - HighBeam Research Press Release: Sanofi Aventis : New Study Results Support the "Basal ... - Sep 10, 2008 Article: Lantus(R) (Insulin Glargine [rDNA Origin] Injection) ... PR Newswire; January 8, 2001 ; 700+ words ... ... target fasting blood glucose of 119 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Exubera Effective in Diabetes Patients who Have … - Sep 14, 2006 14 /PRNewswire-FirstCall/ -- Adult patients with diabetes who took Exubera(R) (insulin human [rDNA origin]) inhalation powder were able to safely maintain ... Pay-Per-View - PR Newswire - HighBeam Research … from the FDA for new labeling for NovoLog (insulin aspart [rDNA... - May 12, 2008 Novo Nordisk has received approval from the FDA for new labeling for NovoLog (insulin aspart [rDNA origin] injection) for continuous subcutaneous insulin ... $9.94 - Drug Topics - Alacra Store Article: Insulin regimens for type 2 diabetes compared.(Metabolic … - Oct 1, 2007 Article: Lantus (insulin glargine (rDNA origin) injection) ... Business Wire; May 22, 2001 ; 700+ words ... ... Aventis Pharmaceuticals announced today that ... Pay-Per-View - Family Practice News - HighBeam Research Press Release: Actress Aida Turturro Tells Americans to Start Now to... - Nov 1, 2007 Life Science Weekly; June 23, 2009 ; 700+ words ... ... daily, already taking basal insulin, Lantus(R) (insulin glargine [rDNA origin ... group study in ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Pfizer's Exubera draws its last breath; Dr. Nick … - Oct 19, 2007 Biotech Business; August 1, 2007 ; 700+ words ... ... declines in lung function in diabetes patients who took Exubera (insulin human [rDNA origin]) ... Pay-Per-View - M2 Presswire - HighBeam Research Article: Noticeboard.(nursing services ) - Journal of Diabetes... - Feb 1, 2005 EMEA) approved the insulin analogue NovoRapid (insulin aspart [rDNA origin]) for ... aspart has thoroughly demonstrated." NovoRapid (NovoLog in the US) is a ... Pay-Per-View - Journal of Diabetes Nursing - HighBeam Research Article: YOUE LIFE: Cost denies diabetics a better way of life.(Featur... - Apr 23, 2006 Biotech Business; August 1, 2007 ; 700+ words ... ... declines in lung function in diabetes patients who took Exubera (insulin human [rDNA origin]) ... Pay-Per-View - Sunday Mercury - HighBeam Research Serono Announces the Availability of Saizen(R) for Adult Growth … - Jan 10, 2005 Saizen(R) [somatropin (rDNA origin) for injection] is a human growth hormone produced by recombinant DNA technology. The recommended dose for adults at the ... RedOrbit Tercica Launches Increlex In The US, Long-Term Treatment Of Growth … - Jan 6, 2006 The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by ... Medical News Today - Medical News Today (press release) Nastech announces positive Phase I clinical results of insulin nasal... - Dec 6, 2006 ...nasal spray formulations, NovoLog insulin aspart (rDNA origin) injection and Exubera (insulin human-rDNA origin) Inhalation Powder in healthy subjects. ... Pay-Per-View - Company Reports - Factiva, from Dow Jones New Data Support Long-Term Efficacy and Safety in Patients Who Took … - Sep 18, 2007 A second eight-day, exploratory study with Exubera and Lantus([R]) (insulin glargine [rDNA origin] injection) in patients with type 2 diabetes not ... Free with registration - Business Wire - AccessMyLibrary.com Tercica, Genentech Announce Agreement for Nurtopin AQ and Increlex - Jul 13, 2007 Nutropin AQ (somatropin (rDNA origin)) and Increlex (mecasermin (rDNA origin) injection) were originally designed and formulated to be combined and ... FDA news - FDA news (subscription) New Long-Acting Insulin Analog Levemir(R) Now Available in United … - Mar 28, 2006 Levemir (insulin detemir [rDNA origin] injection) is a long-acting basal insulin analog indicated for once- or twice-daily subcutaneous administration for ... RedOrbit INSMED INC - INSM: FDA to Review Complete Response to Approvable … - Oct 25, 2005 The FDA has not yet determined whether the approval and granting of orphan exclusivity for mecasermin (rDNA origin) for Severe Primary IGF-1 deficiency will ... Pay-Per-View - Knobias - Factiva, from Dow Jones FDA Accepts Tercica's Increlex(TM) New Drug Application With Priority... - May 2, 2005 The company's first product candidate, Increlex(TM) (mecasermin [rDNA origin] injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), ... RedOrbit |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |